bpc-157 fda warning letter compounding of the Federal Food, Drug, and Cosmetic Act (FDCA).* What's behind the push to
Description
Each sterile vial contains a total of 10mg comprising 5mg BPC-157 and 5mg TB-500 supplied for laboratory research use only
Proper handling secures the integrity of the solution throughout the usage period
Long-term continuous use (years) safety unknown
Molecular reprogramming and phenotype switching in Staphylococcus aureus lead to high antibiotic persistence and affect therapy success
